Inappropriate use of antibiotics in hospitals: The complex relationship between antibiotic use and antimicrobial resistance

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue SUPPL. 4, 2013, Pages 3-11

  Cantón, Rafael ^a,b,c   Horcajada, Juan Pablo ^d   Oliver, Antonio ^b,e   Garbajosa, Patricia Ruiz ^a,b   Vila, Jordi ^b,f  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CSIC   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

Author keywords

Antibiotic use; Antimicrobial resistance; Multi drug resistant bacteria; Selection compartments

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULFANILAMIDE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; CLOSTRIDIUM DIFFICILE; DETOXIFICATION; DISEASE TRANSMISSION; DRUG EXPOSURE; DRUG USE; ESCHERICHIA COLI; GENE INSERTION SEQUENCE; GENE MUTATION; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HOSPITAL; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SKIN FLORA; STENOTROPHOMONAS MALTOPHILIA; SUSCEPTIBLE POPULATION; UNITED KINGDOM; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

ANTIBIOTIC USE; ANTIMICROBIAL RESISTANCE; BACTERIAS MULTIRRESISTENTES; COMPARTIMENTOS DE SELECCIÓN; MULTI-DRUG-RESISTANT BACTERIA; SELECCIÓN DE RESISTENCIA; SELECTION COMPARTMENTS; USO DE ANTIMICROBIANOS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INAPPROPRIATE PRESCRIBING;

EID: 84886875812     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(13)70126-5     Document Type: Article

References (83)

1. B. Almirante, J. Campos, R. Cantón, F. Gudiol, J. Pachón, and A. Pascual Prudent use of antimicrobials: have we done the best we can? The SEIMC and REIPI statement Enferm Infecc Microbiol Clin 28 2010 485 486
2. D.M. Livermore Has the era of untreatable infections arrived? J Antimicrob Chemother 64 Suppl 1 2009 29 36
3. World Health Organization. The evolving threat of antimicrobial resistance. Options for actions. 2012. Available at: http://www.who.int/ patientsafety/implementation/amr/publication/en/index.html.
4. T.M. File Jr., J.S. Solomkin, and S.E. Cosgrove Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs Clin Infect Dis 53 Suppl 1 2011 15 22
5. D.I. Andersson, and D. Huges Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8 2010 260 271
6. R. Cantón, and P. Ruiz-Garbajosa Co-resistance: an opportunity for the bacteria and resistance genes Curr Opin Pharmacol 11 2011 477 485
7. R. Cantón, and M.I. Morosini Emergence and spread of antibiotic resistance following exposure to antibiotics FEMS Microbiol Rev 35 2011 977 991
8. J.W. Mouton, P.G. Ambrose, R. Cantón, G.L. Drusano, S. Harbarth, and A. MacGowan Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective Drug Resist Updat 14 2011 107 117
9. J.W. Mouton, D.F. Brown, P. Apfalter, R. Cantón, C.G. Giske, and M. Ivanova The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach Clin Microbiol Infect 18 2012 37 45
10. J.L. Martínez, F. Baquero, and D.I. Andersson Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics Curr Opin Pharmacol 11 2011 439 445
11. J. Turnidge, and D.I. Paterson Setting and revising antibacterial susceptibility breakpoints Clin Microbiol Rev 20 2007 391 408
12. C. Juan, M.C. Conejo, N. Tormo, C. Gimeno, A. Pascual, and A. Oliver Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study J Antimicrob Chemother 68 2013 619 630
13. G. Kronvall Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints J Clin Microbiol 48 2010 4445 4452
14. F. Baquero Low-level antibacterial resistance: a gateway to clinical resistance Drug Resist Update 4 2001 93 105
15. A. Hakanen, P. Kotilainen, J. Jalava, A. Siitonen, and P. Huovinen Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test J Clin Microbiol 37 1999 3572 3577
16. D.M. Livermore, J.M. Andrews, P.M. Hawkey, P.L. Ho, Y. Keness, and Y. Doi Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 67 2012 1569 1577
17. J.W. Mouton, M.N. Dudley, O. Cars, H. Derendorf, and G.L. Drusano Standardization of pharmacokinetic/pharmacodynamic terminology for anti-infective drugs: an update J Antimicrob Chemother 55 2005 601 607
18. M.R. Jacobs Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters Clin Microbiol Infect 7 2001 589 596
19. M.H. Abdul-Aziz, J.M. Dulhunty, R. Bellomo, J. Lipman, and J.A. Roberts Continuous beta-lactam infusion in critically ill patients: the clinical evidence Ann Intensive Care 2 2012 37
20. V.H. Tam, A. Lui, M.R. Deziel, W. Liu, and G.L. Drusano The relationship between quinolone exposure and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance Antimicrob Agents Chemother 51 2007 744 747
21. F. Baquero, and M.C. Negri Selective compartments for resistant microorganisms in antibiotic gradients Bioessays 19 1997 731 736
22. K. Drlica A strategy for fighting antibiotic resistance ASM News 67 2001 27 33
23. D.I. Andersson, and D. Huges Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8 2010 260 271
24. J. Blázquez, A. Couce, J. Rodríguez-Beltrán, and A. Rodríguez-Rojas Antimicrobials as promoters of genetic variation Curr Opin Microbiol 15 2012 561 569
25. G.L. Drusano, A. Louie, M. Deziel, and T. Gumbo The crisis of resistance: identifying drug exposures to suppress amplification of resistant mutant subpopulations Clin Infect Dis 42 2006 525 532
26. R. Cantón Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting Clin Microbiol Infect 15 Suppl 1 2009 20 25
27. F. Baquero, A.P. Tedim, and T.M. Coque Antibiotic resistance shaping multi-level population biology of bacteria Front Microbiol 4 2013 15
28. F. Baquero, and T.M. Coque Multilevel population genetics in antibiotic resistance FEMS Microbiol Rev 35 2011 705 706
29. R.J. Willems, W.P. Hanage, D.E. Bessen, and E.J. Feil Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance FEMS Microbiol Rev 35 2011 872 900
30. N. Woodford, J.F. Turton, and D.M. Livermore Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance FEMS Microbiol Rev 35 2011 736 755
31. W. Van Schaik, and R.J. Willems Genome-based insights into the evolution of enterococci Clin Microbiol Infect 16 2010 527 532
32. P.A. Hunter, S. Dawson, G.L. French, H. Goossens, P.M. Hawkey, and E.J. Kuijper Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies J Antimicrob Chemother 65 Suppl 1 2010 3 17
33. J. Davies, and D. Davies Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 2010 417 433
34. D.J. Weber, W.A. Rutala, M.B. Miller, K. Huslage, and E. Sickbert-Bennett Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus Clostridium difficile, and Acinetobacter species Am J Infect Control 38 Suppl 1 2010 25 33
35. J.A. Otter, S. Yezli, and G.L. French The role played by contaminated surfaces in the transmission of nosocomial pathogens Infect Control Hosp Epidemiol 32 2011 687 699
36. S.J. Dancer Control of transmission of infection in hospitals requires more than clean hands Infect Control Hosp Epidemiol 31 2010 958 960
37. S. Nseir, C. Blazejewski, R. Lubret, F. Wallet, R. Courcol, and A. Durocher Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit Clin Microbiol Infect 17 2011 1201 1208
38. A. Kramer, I. Schwebke, and G. Kampf How long do nosocomial pathogens persist on inanimate surfaces?. A systematic review BMC Infect Dis 6 2006 130
39. S.L. Warnes, C.J. Highmore, and C.W. Keevil Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: implications for public health MBio 3 6 2012
40. P. Espinal, S. Martí, and J. Vila Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces J Hosp Infect 80 2012 56 60
41. D.L. Monnet, F.M. MacKenzie, J.M. López-Lozano, A. Beyaert, M. Camacho, and R. Wilson Antimicrobial drug use and methicillin-resistant Staphylococcus aureus Aberdeen, 1996-2000 Emerg Infect Dis 10 2004 1432 1441
42. R.E. Polk, C.K. Johnson, D. McClish, R.P. Wenzel, and M.B. Edmond Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities Clin Infect Dis 39 2004 497 503
43. F. Baquero, J.L. Martínez, and R. Cantón Antibiotics and antibiotic resistance in water environments Curr Opin Biotechnol 19 2008 260 265
44. K. Kummerer, and A. Henninger Promoting resistance by the emission of antibiotics from hospitals and households into effluents Clin Microbiol Infect 9 2003 1203 1214
45. S.B. Levy Antibiotic resistance: an ecological imbalance Ciba Found Symp 207 1997 1 9
46. S.J. Dancer, M. Coyne, C. Robertson, A. Thomson, A. Guleri, and S. Alcock Antibiotic use is associated with resistance of environmental organisms in a teaching hospital J Hosp Infect 62 2006 200 206
47. M.J. Bonten, S. Slaughter, A.W. Ambergen, M.K. Hayden, J. Van Voorhis, and C. Nathan The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable Arch Intern Med 158 1998 1127 1132
48. J. Merrer, F. Santoli, C. Appéré de Vecchi, B. Tran, B. De Jonghe, and H. Outin "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit Infect Control Hosp Epidemiol 21 2000 718 723
49. T.C. Smith, M.J. Male, A.L. Harper, J.S. Kroeger, G.P. Tinkler, and E.D. Moritz Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers PLoS One 4 2009 e4258
50. M.J. Bonten, R. Willems, and R.A. Weinstein Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 1 2001 314 325
51. G.G. Perron, G. Bell, and S. Quessy Parallel evolution of multidrug-resistance in Salmonella enterica isolated from swine FEMS Microbiol Lett 281 2008 17 22
52. J.R. Johnson, M.A. Kuskowski, K. Smith, T.T. O'Bryan, and S. Tatini Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods J Infect Dis 191 2005 1040 1049
53. C. Garofalo, C. Vignaroli, G. Zandri, L. Aquilanti, D. Bordoni, and A. Osimani Direct detection of antibiotic resistance genes in specimens of chicken and pork meat Int J Food Microbiol 113 2007 75 83
54. Y. Doi, D.L. Paterson, P. Egea, A. Pascual, L. López-Cerero, and M.D. Navarro Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville Spain. Clin Microbiol Infect 16 2010 33 38
55. L. Jakobsen, P. Garneau, G. Bruant, J. Harel, S.S. Olsen, and L.J. Porsbo Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat Eur J Clin Microbiol Infect Dis 31 2012 1121 1129
56. I. Van Loo, X. Huijsdens, E. Tiemersma, A. De Neeling, N. Van de Sande-Bruinsma, and D. Beaujean Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans Emerg Infect Dis 13 2007 1834 1839
57. P. Gandolfi-Decristophoris, O. Petrini, N. Ruggeri-Bernardi, and E. Schelling Extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy companion animals living in nursing homes and in the community Am J Infect Control 2013 doi: 10. 1016/j. ajic. 2012. 11. 013. [Epub ahead of print]
58. A. Fajardo, and J.L. Martínez Antibiotics as signals that trigger specific bacterial responses Curr Opin Microbiol 11 2008 161 167
59. G.D. Wright The antibiotic resistome: the nexus of chemical and genetic diversity Nat Rev Microbiol 5 2007 175 186
60. B. Halling-Sørensen, S. Nors Nielsen, P.F. Lanzky, F. Ingerslev, H.C. Holten Lützhøft, and S.E. Jørgensen Occurrence, fate and effects of pharmaceutical substances in the environment-a review Chemosphere 36 1998 357 393
61. C.P. Gerba, and J.E. Smith Jr. Sources of pathogenic microorganisms and their fate during land application of wastes J Environ Qual 34 2005 42 48
62. R.V. Tauxe Emerging foodborne pathogens Int J Food Microbiol 78 2002 31 41
63. G. Zarfel, H. Galler, G. Feierl, D. Haas, C. Kittinger, and E. Leitner Comparison of extended-spectrum-β-lactamase (ESBL) carrying Escherichia coli from sewage sludge and human urinary tract infection Environ Pollut 173 2013 192 199
64. R. Cantón, and J. Cobo Consumo de antimicrobianos en el hospital; una relación difícil de medir y compleja de interpretar Enferm Infecc Microbiol Clin 27 2009 437 440
65. O. O'Sullivan, M. Coakley, B. Lakshminarayanan, S. Conde, M.J. Claesson, and S. Cusack ELDERMET Consortium. Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy J Antimicrob Chemother 68 2013 214 221
66. V.I. Enne, D.M. Livermore, P. Stephens, and L.M. Hall Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction Lancet 357 2001 1325 1328
67. SundqvistM, P. Geli, D.I. Andersoon, Sjölund-Karlsson, A. Runehagen, and H. Cars Little evidence for reversibility of thrimethoprim resistance after a drastic reduction in trimethoprim use J Antimicrob Chemother 65 2010 350 360
68. J.J. Rahal, C. Urban, and S. Segal-Maurer Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites Clin Infect Dis 34 2002 499 503
69. A. Fàbrega, S. Madurga, E. Giralt, and J. Vila Mechanism of action of and resistance to quinolones Microb Biotechnol 2 2009 40 61
70. J. Strahilevitz, G.A. Jacoby, D.C. Hooper, and A. Robicsek Plasmid-mediated quinolone resistance: a multifaceted threat Clin Microbiol Rev 22 2009 664 689
71. D.E. Rozen, L. McGee, B.R. Levin, and K.P. Klugman Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob Agents Chemother 51 2007 412 416
72. B.R. Levin Minimizing potential resistance: a population dynamic view Clin Infect Dis 33 Suppl 3 2001 161 169
73. A.M. Bal, A. Kumar, and I.M. Gould Antibiotic heterogeneity: from concept to practice Ann N Y Acad Sci 1213 2010 81 91
74. C.T. Bergstrom, M. Lo, and M. Lipsitch Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals Proc Natl Acad Sci USA 101 2004 13285 13290
75. E.M. Brown, and D. Nathwani Antibiotic cycling or rotation: a systematic review of the evidence of efficacy J Antimicrob Chemother 55 2005 6 9
76. R.G. Masterton Antibiotic heterogeneity Int J Antimicrob Agents 36 Suppl 3 2010 15 18
77. A. Sandiumenge, E. Díaz, A. Rodríguez, L. Vidaur, L. Canadell, and M. Olona Impact of diversity of antibiotic use on the development of antimicrobial resistance J Antimicrob Chemother 57 2006 1197 1204
78. Y. Takesue, K. Nakajima, K. Ichiki, M. Ishihara, Y. Wada, and Y. Takahashi Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria J Hosp Infect 75 2010 28 32
79. P.D. Tamma, S.E. Cosgrove, and L.L. Maragakis Combination therapy for treatment of infections with gram-negative bacteria Clin Microbiol Rev 25 2012 450 470
80. U. Theuretzbacher Future antibiotics scenarios: is the tide starting to turn? Int J Antimicrob Agents 34 2009 15 20
81. F.C. Tenover Potential impact of rapid diagnostic tests on improving antimicrobial use Ann N Y Acad Sci 1213 2010 70 80
82. J.A. Foushee, N.H. Hope, and E.E. Grace Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays J Antimicrob Chemother 67 2012 2560 2569
83. V. Schechner, E. Temkin, S. Harbarth, Y. Carmeli, and M.J. Schwaber Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance Clin Microb Rev 26 2013 289 307